Cingulate (CING) Prepaid Assets (2021 - 2026)
Cingulate's (CING) quarterly Prepaid Assets came in at $1.0 million in Q4 2025, up 4957.79% YoY from $20698.0 in Q4 2024, and up 1089.94% on a QoQ basis from $87976.0 in Q3 2025.
Cingulate (CING) Prepaid Assets (2021 - 2026) Analysis & Trends
Cingulate (CING) has 5 years of Prepaid Assets data on file, last reported at $1.0 million in Q4 2025.
- Quarterly Prepaid Assets rose 4957.79% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 4957.79% YoY) and the FY2025 annual result came in at $1.0 million, up 4957.79% from the prior year.
- Prepaid Assets advanced to $1.0 million in Q4 2025, from $87976.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.0 million in Q3 2022 to a low of $20698.0 in Q4 2023.
- A 5-year average of $977908.1 and a median of $995647.5 in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets sank 97.73% — and 2025, when it soared 4957.79%.
- Tracing CING's Prepaid Assets over 5 years: stood at $1.7 million in 2021, then slumped by 72.2% to $472152.0 in 2022, then plunged by 95.62% to $20698.0 in 2023, then changed by 0.0% to $20698.0 in 2024, then soared by 4957.79% to $1.0 million in 2025.
- The last three Prepaid Assets figures came in at $1.0 million (Q4 2025), $87976.0 (Q3 2025), and $944433.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cingulate | 72.85 Mn | 72.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.77 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 87,976.00 |
| Mar 31, 2025 | 944,433.00 |
| Dec 31, 2024 | 20,698.00 |
| Sep 30, 2024 | 20,698.00 |
| Jun 30, 2024 | 113,451.00 |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 20,698.00 |
| Sep 30, 2023 | 910,286.00 |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.98 Mn |
| Dec 31, 2022 | 472,152.00 |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 1.70 Mn |